As shown in Fig. 2F and Table 1, WWP2 was significantly upregulated in GC tissues (78/130, 60%), and the staining of WWP2 was markedly enhanced with increasing clinical TNM stage, indicating that WWP2 overexpression contributes to GC tumorigenesis and progression. The gene discussed is WWP2; the disease is gastric cancer.